Sources | Names Used |
---|---|
CTRPv2 | decitabine:carboplatin (1:1 mol/mol) |
PharmacoGx | decitabine:carboplatin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-1035H13.3 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | NTN5 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
mRNA | ZNF814 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
mRNA | PHYHD1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.003 |
mRNA | RP11-146B14.1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | POPDC2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
mRNA | ARID1A | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
mRNA | C4orf47 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.004 |
mRNA | VPS4B | CTRPv2 | pan-cancer | AAC | 0.082 | 0.004 |
mRNA | HAAO | CTRPv2 | pan-cancer | AAC | -0.083 | 0.004 |